{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:24:40Z","timestamp":1788323080301,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002711","name":"Ahi Evran Universitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humimm.2026.111814","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:36:52Z","timestamp":1785159412000},"page":"111814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating immunogenetic stratification and follicular immune dynamics: An evolving framework for CAR-Treg therapy in antibody-mediated rejection"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5010-7955","authenticated-orcid":false,"given":"Nurten Sayin","family":"Ekinci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-9345","authenticated-orcid":false,"given":"Habibe Sema Arslan","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.humimm.2026.111814_bb0005","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2026.111814_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00469","article-title":"Reflections on HLA epitope-based matching for transplantation","volume":"7","author":"Duquesnoy","year":"2016","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.111814_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4285\/ctr.25.0046","article-title":"Eplet mismatch analysis in kidney transplantation: from concept to clinical practice","volume":"39","author":"Lee","year":"2025","journal-title":"Clin. Transplant Res."},{"key":"10.1016\/j.humimm.2026.111814_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2025.1710058","article-title":"The role of eplet matching in solid organ transplantation","volume":"4","author":"St\u00f6gner","year":"2025","journal-title":"Front. Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2026.111814_bb0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.transproceed.2024.01.030","article-title":"Impact of HLA Eplet mismatch on De novo donor specific antibody formation after kidney transplantation","volume":"56","author":"Yanyiam","year":"2024","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.humimm.2026.111814_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1508796","article-title":"De novo donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment","volume":"16","author":"Chou-Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111814_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02000","article-title":"Analysis of T and B cell epitopes to predict the risk of de novo donor-specific antibody (DSA) production after kidney transplantation: a two-center retrospective cohort study","volume":"11","author":"Sakamoto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111814_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1447141","article-title":"HLA-DR\/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic southeast Asian kidney transplant recipients on different immunosuppression regimens","volume":"15","author":"Wong","year":"2024","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.humimm.2026.111814_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15346","article-title":"Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation","volume":"103","author":"Kardol-Hoefnagel","year":"2024","journal-title":"HLA"},{"issue":"03","key":"10.1016\/j.humimm.2026.111814_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.21926\/obm.transplant.2503258","article-title":"Antibody-mediated rejection in kidney transplantation: immunopathogenesis, innate\u2013adaptive crosstalk, and therapeutic advances","volume":"09","author":"Surdi","year":"2025","journal-title":"OBM Transplantation"},{"issue":"12","key":"10.1016\/j.humimm.2026.111814_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12124130","article-title":"Pathophysiology of rejection in kidney transplantation","volume":"12","author":"Tamargo","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.humimm.2026.111814_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682334","article-title":"Approaches for controlling antibody-mediated allograft rejection through targeting B cells","volume":"12","author":"Matsuda","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111814_bb0065","doi-asserted-by":"crossref","DOI":"10.5500\/wjt.v16.i1.111524","article-title":"Update on diagnostic and therapeutic strategies for antibody-mediated rejection in kidney transplantation","volume":"16","author":"Elahi","year":"2026","journal-title":"World J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2026.111814_bb0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.it.2023.11.005","article-title":"Chimeric antigen receptor T(reg) therapy in transplantation","volume":"45","author":"Eskandari","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.humimm.2026.111814_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111814_bb0080","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/ajt.15787","article-title":"Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients","volume":"20","author":"Sicard","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2026.111814_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40472-020-00285-z","article-title":"CAR-Tregs as a strategy for inducing graft tolerance","volume":"7","author":"Wagner","year":"2020","journal-title":"Curr. Transplant Rep."},{"issue":"4","key":"10.1016\/j.humimm.2026.111814_bb0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.humimm.2026.111814_bb0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40472-015-0058-5","article-title":"Adoptive T regulatory cell therapy for tolerance induction","volume":"2","author":"Cabello-Kindelan","year":"2015","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.humimm.2026.111814_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861607","article-title":"Epigenetic control of regulatory T cell stability and function: implications for translation","volume":"13","author":"Joudi","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.111814_bb0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111814_bb0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2026.111814_bb0115","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ajt.14175","article-title":"Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor","volume":"17","author":"Noyan","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"557","key":"10.1016\/j.humimm.2026.111814_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.111814_bb0125","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/s41467-021-26844-1","article-title":"Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction","volume":"12","author":"Lamarth\u00e9e","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.humimm.2026.111814_bb0130","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ekir.2022.03.030","article-title":"Study design: human leukocyte antigen class I molecule a(\u2217)02-chimeric antigen receptor regulatory T cells in renal transplantation","volume":"7","author":"Schreeb","year":"2022","journal-title":"Kidney Int. Rep."},{"issue":"6","key":"10.1016\/j.humimm.2026.111814_bb0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/tan.14591","article-title":"Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients","volume":"99","author":"Cremoni","year":"2022","journal-title":"Hla"},{"issue":"5","key":"10.1016\/j.humimm.2026.111814_bb0140","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.humimm.2026.111814_bb0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jcyt.2024.12.015","article-title":"CXCR5-targeted chimeric antigen receptor T regulatory cells for the selective inhibition of follicular helper T cell and B cell interaction","volume":"27","author":"Murai","year":"2025","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.humimm.2026.111814_bb0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/nep.14035","article-title":"Personalized immunosuppression after kidney transplantation","volume":"27","author":"Cheung","year":"2022","journal-title":"Nephrology (Carlton)"},{"issue":"8","key":"10.1016\/j.humimm.2026.111814_bb0155","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2026.111814_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15104","article-title":"Evaluation of the relationship between de-novo DSA development and CXCR5+PD-1+CD8+ T cells and PD-1\/PD-L1 mRNA expression in kidney transplant recipients","volume":"37","author":"Ekinci","year":"2023","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2026.111814_bb0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.humimm.2026.111814_bb0170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.humimm.2018.01.009","article-title":"Cellular and functional biomarkers of clinical transplant tolerance","volume":"79","author":"Mathew","year":"2018","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2026.111814_bb0175","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2026.111814_bb0180","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1038\/s41467-025-64945-3","article-title":"HLA matching or CRISPR editing of HLA class I\/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model","volume":"16","author":"McCallion","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111814_bb0185","series-title":"A study to evaluate the safety and tolerability of QEL-001 in liver transplant patients (LIBERATE)","author":"ClinicalTrials.gov","year":"2022"},{"key":"10.1016\/j.humimm.2026.111814_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1509956","article-title":"From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases","volume":"15","author":"Bulliard","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2026.111814_bb0195","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1111\/ajt.16095","article-title":"Applications of CRISPR technologies in transplantation","volume":"20","author":"Kuscu","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2026.111814_bb0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926001606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926001606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:11:59Z","timestamp":1788322319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0198885926001606"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111814","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating immunogenetic stratification and follicular immune dynamics: An evolving framework for CAR-Treg therapy in antibody-mediated rejection","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111814"}}